(Total Views: 267)
Posted On: 10/04/2022 10:06:22 AM
Post# of 58

$ABEO News Article - Abeona Therapeutics Announces Completion of Patient Follow-up in Pivotal Phase 3 VIITAL(TM) Study of EB-101 in Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) https://marketwirenews.com/news-releases/abeo...41117.html


My Twitter: WhyteStocks